Peter C. Gerszten, MD, MPH, is the Peter E. Sheptak Professor of Neurosurgery at the University of Pittsburgh. Dr. Gerszten joined the Department of Neurological Surgery and the UPMC Spine Services Division in 1999. He received his undergraduate degree from the University of Virginia and completed his medical degree at the Johns Hopkins School of Medicine. He completed his residency in neurological surgery at the University of Pittsburgh Medical Center. Dr. Gerszten obtained a master of public health degree from the University of Pittsburgh Graduate School of Public Health. He completed a fellowship in spinal surgery at the University of Pittsburgh Medical Center.
Dr. Gerszten specializes in disorders of the spine, focusing on spinal neoplasms. His clinical interests include minimally invasive approaches to the treatment of spinal disorders and spinal tumors. Dr. Gerszten’s area of research is the application of outcomes research to spinal surgical interventions. He is a pioneer in the field of spine radiosurgery.
Dr. Gerszten is co-editor of the 2015 second edition Spine Radiosurgery, an authoritative textbook—and the first of its kind—on all aspects of spine radiosurgery. He is also co-editor of the book Controversies in Stereotactic Radiosurgery: Best Evidence Recommendations, a 277-page look into an evidence-based approach to stereotactic radiosurgery for the brain and spine.
Dr. Gerszten currently serves on the editorial boards of Neurosurgery, The Spine Journal, The Journal of Radiosurgery and SBRT and Neurosurgical Focus. He also serves on the board of directors of The Radiosurgery Society.
Specialized Areas of Interest
American Board of Neurological Surgery
Professional Organization Membership
Education & Training
- BA, University of Virginia, 1988
- MD, Johns Hopkins School of Medicine, 1992
- MPH, University of Pittsburgh Graduate School of Public Health, 1998
- Residency, Neurological Surgery, University of Pittsburgh, 1999
- Fellowship, Spine Surgery, University of Pittsburgh, 2000
Honors & Awards
- Pittsburgh’s Best Doctors, Pittsburgh Magazine, 2018
Kashkoush A, Agarwal N, Paschel E, Goldschmidt E, Gerszten PC. Evaluation of a hybrid dynamic stabilization and fusion system of the lumbar spine: A 10-year experience. Cureus 8(6):e637, 2016.
Mashaly H, Paschel EE, Khattar NK, Goldschmidt E, Gerszten PC. Posterior lumbar dynamic stabilization instead of arthrodesis for symptomatic adjacent-segment degenerative stenosis: Description of a novel technique. Neurosurgical Focus 40(1):E5, 2016.
Caruso JP, Cohen-Inbar O, Bilsky MH, Gerszten PC, Sheehan JP. Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma. Neurosurgical Focus 38(3):E6, 2015.
Redmond KJ, Sahgal A, Foote M, Knisely J, Gerszten PC, Chao ST, Suh JH, Sloan AE, Change EL, Machtay M, Lo SS. Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk-benefit ratio. Future Oncology 11(17):2405-15, 2015.
Thibault I, Chang EL, Sheehan J, Ashluwalia MS, Guckenberger M, Sohn M-J, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten PC, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlibngs MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A. Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncology 16(16):e595-603, 2015.
Ryu S, Pugh SL, Gerszten PC, Yin F-F, Timmerman RD, Hitchcock YJ, Movas B, Kanner AA, Berk LB, Followill DS, Kachnic LA. RTOG 0631 phase II/III study of image-guided stereotactic radiosurgery for localized (1-3) spine metastases: Phase II results. Practical Radiation Oncology 4:76-81, 2014.
Guckenberger M, Mantel F, Gerszten PC, Flickinger JC, Sahgal A, Letourneau D, Grills IS, Jawas M, Fahim DK, Shin JH, Winey B, Sheehan J, Kersh R. Safety and efficacy of Stereotactic Body Radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis. Radiation Oncology 9:226, 2014.
Gerszten PC. Spine metastases: From radiotherapy, surgery, to radiosurgery. Neurosurgery 61:16-25, 2014.
Sahgal A, Weinberg V, Chang E, Chao S, Muacevic A, Gorgulho A, Gibbs IC, Gerszten PC, Ryu S, Soltys S, Angelov L, Shung Wong C, Ma L, Larson DA. Probabilities of radiation myelopathy specific to stereotactic body radiotherapy to guide safe practice. Int J Rad Oncol Biol Phys 85(2):341-347, 2013.
Bartynski WS, DeJohn LM, Rothfus WE, Gerszten PC. Progressive-onset versus injury-associated discogenic low back pain: Features of disc internal derangement in patients studied with provocation lumbar discography. Interventional Neuroradiology 19(1):10-20, 2013.
A complete list of Dr. Gerszten's publications can be reviewed through the National Library of Medicine's publication database.
Dr. Gerszten serves as the neurosurgical principal investigator of the National Cancer Institute Supported Radiation Therapy Oncology Group Cooperative Clinical Trial entitled “Phase II/III Study of Single Dose Radiosurgery for Localized Spinal Metastases”. Dr. Gerszten continues to investigate the expanding role of radiosurgery for the treatment of both malignant as well as benign tumors of the spine. Ongoing research includes the incorporation of spine radiosurgery into minimally invasive and percutaneous spine procedures. Dr. Gerszten’s research related to spine radiosurgery is conducted in cooperation with the International Spine Oncology Study Group as well as the International Spine Radiosurgery Consortium.
Dr. Gerszten successfully developed and performed the first ever use of radiosurgery as an ablative tool for extracranial targets in a small animal model. This study allowed for the evaluation of the clinical and histopathological effects of high dose radiosurgery on the rat dorsal root ganglion. The goal of these investigations is to evaluate the use of radiosurgery as a viable treatment option for neuromodulation of pain of spinal origin. This year, Dr. Gerszten continued his translational research investigations into the use of radiosurgery for extracranial neuromodulation. Studies were performed that included the development of more comprehensive techniques to safely and accurately deliver high dose radiosurgery to the dorsal root ganglion in animal models. Work was carried out in order to determine if lower doses could be equally as effective in modulating spinal pain generators.
Dr. Gerszten’s clinical research focuses on the adoption of minimally invasive surgical treatments for disorders of the spine. Such minimally invasive techniques allow for decreased morbidity while improving outcomes in neurosurgical patients. Dr. Gerszten continues to expand and systematically analyze the clinical outcomes and safety profiles associated with the use of new spinal implant devices. Other clinical research has documented the safety and efficacy of minimally invasive sacroiliac joint fusions using titanium screw implants for sacroiliac joint dysfunction. Finally, Dr. Gerszten continues to evaluate the role of posterior lumbar dynamic stabilization for motion preservation.
Dr. Gerszten served as a member of the United States Panel for Appropriate Management of Osteoporotic Vertebral Compression Fractures. This independent panel comprising neurosurgeons, orthopedic surgeons, radiologists, and pain management physicians from throughout the country will meet on a regular basis to help set national policy for the best management practices for patients with vertebral compression fractures.
Experto dice que la Radiocirugía evita la cirugía en el tratamiento de metástasis que afectan a la columna vertebral
November 6, 2013
SBRT in tumours of the spinal column
July 30, 2013
La Radiocirugía. una alternativa eficaz para evitar la cirugía en el tratamiento de metástasis de la columna vertebral
June 11, 2013
Evaluar al paciente, clave en el manejo de columna vertebal
February 1, 2012
Stereotactic Radiosurgery Matures Into Mainstream Extracranial Technique (pdf)